Zealand moves US collaboration into phase II
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article7575832.ece/ALTERNATES/schema-16_9/Zealand%2520Pharma%2520forskning2.jpg)
The partnership between Denmark’s Zealand Pharma and US-based medical device maker Beta Bionics is moving forward with the first patients does in a new phase IIa trial, the biotech wrote in a press release Tuesday.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Pace sets Zealand apart from larger rivals
For abonnenter
Zealand's big money dreams can finally come true
For abonnenter